Latin American Journal of Pharmacy



 
 
 Vol. 34 Nş 9
Lat. Am. J. Pharm. 34 (9): 1697-1908 (2015)  


REGULAR ARTICLES
 
Development and In Vitro Evaluation of Acyclovir Rapid Dissolving Tablets: a Solubility and Bioavailability Enhancement Study  *
MAHMOOD A., AHMAD M., SARFRAZ R.M., MINHAS M.U. & YAQOOB A.  (1701)
 
 
Benzoyl Peroxide-Loaded PCL Microparticles: Physicochemical Characterization and In Vitro Antibacterial and Permeation Studies  *
JUSTUS B., NADAL J.M., ALMEIDA M.A., JANZEN M.E.S., BUDEL J.M., ESMERINO L.A., ZAWADZKI S.F., PAULA J.P. de & FARAGO P.V.  (1710)
 
 
Formulation and Characterization of Biodegradable Implants of Ibuprofen for Prolonged Delivery in Post Traumatic Spinal Injuries  *
XIAO W. & DAI M.  (1718)
 
 
Comparison of Anti-sympathetic Activity between Dexmedetomidine and Metoprolol Tartrate in Patients with Acute Left Heart Failure  *
FANG Z., ZHOU C., ZHENG X., FANG K., CHEN L. & SHENG C.  (1723)
 
 
Patterns of Over-The-Counter Analgesic Use and Drug Interactions between Over-The-Counter Analgesics and Prescription Drugs  *
LEE K.J., YOO Y.P. & LEE Y.J.  (1729)
 
 
Development of High Performance Liquid Chomatography Method for Determination of Flurbiprofen and Ranitidine in Bilayer Tablets  *
HANIF M., NAZIR N., ZIA M.U., CHUDHARY B.A., ABBAS G., RANA S.J. & ZAMAN M.  (1737)
 
 
Fast and Eco-friendly UV Spectrophotometric and HPLC Assay Methods for Estimation of Esmolol in Pharmaceutical Formulation  *
SOUZA T.V.A., TAKANO D.E.N., KASSAB N.M., AMARAL M.S. do, SANTORO M.I.R.M. & SINGH A.K.  (1743)
 
 
Determination and Pharmacokinetic Study of Gefitinib in Rat Plasma by a Simple UPLC-MS/MS Method  *
LI R., CHEN J., SUN W., LI M., SUN K. & WANG J.  (1749)
 
 
Pharmacokinetics and Safety of Melatonin Prolonged-Release Tablets in Healthy Chinese Subjects  *
WANG M., ZHANG Q., ZHOU W., ZONG S. & WANG H.  (1754)
 
 
Quantification and Pharmacokinetic Study of Sorafenib in Rat Plasma Using UPLC-MS/MS  *
SHI X., GAN D., LOU J., ZHU B., HU A. & ZHU D.  (1761)
 
 
Effect of the Molecular Properties of Diallyl Trisulfide Analogues on ROS Production  *
HE, X.  (1766)
 
 
Design and Synthesis of 1,3,4-Thiadiazole Derivatives as Type IV Collagenase Inhibitors  *
CHEN X., WANG D., KUANG B., LI S., & TU G.  (1772)
 
 
Preparation and Characterization of Folate-Conjugated Recombinant Human Serum Albumin Nanoparticles for Targeted Drug Delivery  *
ZHAO D., ZHAO X., ZU Y., JIN X., JIANG S. & ZHANG Z.  (1778)
 
 
Analysis of Short-term efficacy of Pegylated Interferon α-2a and Interferon α-2a in the Treatment for Chronic Hepatitis C  *
ZHANG H., WANG M., YU Z., SUN C., LI Z. & WU S.  (1785)
 
 
Pharmacokinetic Study of Dabrafenib in Rat Plasma by UPLC-MS/MS  *
LUO X., GENG P., ZHANG J., ZHANG L., LIN Y., XU M., WEN C. & SHENTU Y.  (1791)
 
 
Fabrication, Preliminary Stability Evaluation and In Vitro Characterization of Polysiloxane Polyalkyl Polyether Copolymer-Based Cosmetic Emulsion  *
ARSHAD A.I., KHAN H.M.S. & AKHTAR N.  (1797)
 
 
PEGylated Niosomes as Delivery Systems Efficiently Prolonged the Clearance Time of 2- Hydroxy-1,7-Dimethoxyxanthone In Vivo  *
ZUO J., ZHANG W., XIA Y., LI X., LUAN J., & CHEN J.  (1808)
 
 
Fluoroquinolone Prescribing Patterns in the Private Healthcare Sector of South Africa, 2005- 2012  *
AGYAKWA W., LUBBE M.S., BURGER J.R., KATENDE-KYENDA N.L., COCKERAN M. & MALIK M.  (1815)
 
 
Antioxidant, Antimicrobial and Pediculicidal Activities of Eucalyptus benthamii Essential Oil  *
DÖLL-BOSCARDIN P.M., BORSATO D.M., MIRANTE D.C., NAKASHIMA T., BUDEL J.M., KOVALICZN R.A., MAIA B.H.L.N.S., de PAULA J.P. & FARAGO P.V.  (1823)
 
 
Influence of Saikosaponin on Behavior and Hippocampal Neurons in Rat Depression Models  *
ZHANG J., CAI Z., XU G., DONG H., WEN Q., YU X., WANG S. & ZHANG X.  (1830)
 
 
Determination and Validation of Imperialine in Rat Plasma by Ultra-Performance Liquid-Chromatography with Tandem Mass Spectrometry  *
WU Q., WANG C., LIN Y., YANG S., WU Y., FAN L., GU K., HU Y., WEN C. & LIN C.  (1836)
 
 
Synthesis and Characterization of Macroporous Poly(Acrylamide-Methacrylic Acid) Cryogel and its Interaction with Clarithromycin  *
HEPOKUR A.I., HEPOKUR C. & KARİPER I.A.  (1842)
 
 
Development and In Vitro Evaluation of Floating Gastro-Retentive Matrix Tablet for a Model Water Soluble Drug Prepared with the Novel Blends of Chitosan and Polycaprolactone  *
HUSSAIN T., HUSSAIN A., SHAMIM R., SHEHZAD M.K., DANISH Z., HUSSAIN K., & BUKHARI N.I.  (1849)
 
 
Paeonol Inhibits Overproliferation of VSMCs in Ox-LDL-Injured Co-Cultured System by Suppression of ET-1 Expression  *
WU H., SU X. & DAI M.  (1858)
 


SHORT COMMUNICATIONS
 
Antibacterial and Membrane-damaging Activities of Rosmarinic Acid against Pathogenic Organisms of Acne  *
HU D., ZHAO J., GU Y., XU H., & LI X.  (1866)
 
 
Docking for Explaining the Inhibition of Rivaroxaban Derivatives Towards the Metabolism of Propofol, an Important Anaesthetic Drug  *
LI Z., SHI C., JIN J., MA J., LI T. & LI K.  (1871)
 
 
Synthesis, Crystal Structures and Anticancer Activities of Two Naphthol Derivatives  *
LIAO R. & ZHANG Y.  (1876)
 
 
The Metabolism of Liver Cancer Treatment Drug Sorafenib is Affected by Acetaminophen Treatment  *
YU H., WANG Y., SONG D. & LIU L.  (1881)
 
 
Optimized Incubation System for Psoralea corylifolia Linn. - Propofol Interaction  *
DING Y., YU Z., CHEN L., PAN W., JIN J., CHI Y., LI Z., LI K., MA J., YU J. & SHI C.  (1886)
 
 
Synthesis and In Vitro Evaluation of Urease Inhibitory Activity of α-Naphthol and β-Naphthol Derivatives  *
MENG X., LIU L., ZHANG H., & SUN M.  (1891)
 
 
Metabolic Interference of Bruceantinol towards Cytochrome P450 (CYP) 2C9-Catalyzed Metabolism of Propofol  *
XING C., LIU H., & WU M.  (1894)
 
 
Drug-Drug Interaction between the Infection Diseases Treatment Drugs Ketoconazole and Bruceine B  *
LIU Y. & GUAN B.  (1897)
 
 
Mechanism Investigation for Piceatannol-Propofol Interaction  *
JIN L., WU G., ZHAO Z., ZHENG D. & CUI X.  (1900)
 
 
Synthesis and Antitumor Activity of a Novel Biscoumarin and its Corresponding Epoxydicoumarin  *
ZHU Y., TAI B., XU T. & LI H.  (1905)
 



_________________

* English

** Portugûes

 
LOG-IN                                 

User


Password




Forgot your password?






ACTIONS ___     ___ _         

Submit Article

Check Manuscript Status

Suscription

Free Sample Issue



STATISTICS ___     ___        

JCR Impact Factor 2014:
0.372

Issues per year: 10

ISSN 0326 2383 (printed ed.)

ISSN 2362-3853 (on line ed.)
 




© Latin American Journal of Pharmacy 2017 | All rights reserved

Developed by: CAFFINI / COMMUNICATION & DESIGN